{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:54:24Z","timestamp":1780538064928,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.clbc.2021.01.008","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T11:36:40Z","timestamp":1611056200000},"page":"e427-e433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Influential Factors on Risk-reduction Mastectomy in a High-risk Breast Cancer Population With Genetic Predispositions"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0075-1990","authenticated-orcid":false,"given":"Grace","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambuj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1756-7279","authenticated-orcid":false,"given":"Marie Catherine","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2021.01.008_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","article-title":"Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer","volume":"340","author":"Hartmann","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2021.01.008_bib2","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/annonc\/mdt134","article-title":"Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis","volume":"24","author":"Heemskerk-Gerritsen","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2021.01.008_bib3","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1245\/s10434-009-0641-z","article-title":"Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer","volume":"16","author":"Arrington","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.01.008_bib4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.surge.2014.02.005","article-title":"Increasing trend of contralateral prophylactic mastectomy: what are the factors behind this phenomenon?","volume":"12","author":"Soran","year":"2014","journal-title":"Surgeon"},{"key":"10.1016\/j.clbc.2021.01.008_bib5","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1089\/jwh.2016.5931","article-title":"Breast cancer risk reduction decisions of the BRCA-positive patient: an observational study at a single institution","volume":"26","author":"Johns","year":"2017","journal-title":"J\u00a0Womens Health (Larchmont)"},{"key":"10.1016\/j.clbc.2021.01.008_bib6","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2021.01.008_bib7","first-page":"CD002748","article-title":"Risk-reducing mastectomy for the prevention of primary breast cancer","volume":"4","author":"Carbine","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clbc.2021.01.008_bib8","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa1400382","article-title":"Breast-cancer risk in families with mutations in PALB2","volume":"371","author":"Antoniou","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2021.01.008_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jamaoncol.2014.168","article-title":"Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond","volume":"1","author":"Hansford","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clbc.2021.01.008_bib10","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1002\/cncr.30248","article-title":"Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort","volume":"122","author":"Mai","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2021.01.008_bib11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","article-title":"Lifetime cancer risks in individuals with germline PTEN mutations","volume":"18","author":"Tan","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2021.01.008_bib12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa1400382","article-title":"Breast-cancer risk in families with mutations in PALB2","volume":"371","author":"Antoniou","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2021.01.008_bib13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000314266","article-title":"Factors that affect patients\u2019 decision-making about mastectomy or breast conserving surgery, and the psychological effect of this choice on breast cancer patients","volume":"5","author":"Gumus","year":"2010","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.clbc.2021.01.008_bib14","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/pon.5166","article-title":"Risk-reducing surgery in BRCA1\/BRCA2 mutation carriers: are there factors associated with the choice?","volume":"28","author":"Manoukian","year":"2019","journal-title":"Psychooncology"},{"key":"10.1016\/j.clbc.2021.01.008_bib15","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1245\/s10434-017-5959-3","article-title":"Clinical decision-making in patients with variant of uncertain significance in BRCA1 or BRCA2 genes","volume":"24","author":"Welsh","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.01.008_bib16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1245\/s10434-014-4033-7","article-title":"\u2018Taking control of cancer\u2019: understanding women\u2019s choice for mastectomy","volume":"22","author":"Covelli","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.01.008_bib17","doi-asserted-by":"crossref","first-page":"e539","DOI":"10.1016\/j.clbc.2017.12.013","article-title":"Review of factors influencing women\u2019s choice of mastectomy versus breast conserving therapy in early stage breast cancer: a systematic review","volume":"18","author":"Gu","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2021.01.008_bib18","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10897-009-9245-9","article-title":"Women\u2019s decision making about risk-reducing strategies in the context of hereditary breast and ovarian cancer: a systematic review","volume":"18","author":"Howard","year":"2009","journal-title":"J\u00a0Genet Couns"},{"key":"10.1016\/j.clbc.2021.01.008_bib19","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/s41431-017-0057-3","article-title":"Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history","volume":"26","author":"Meiser","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.clbc.2021.01.008_bib20","doi-asserted-by":"crossref","first-page":"329.e1","DOI":"10.1016\/j.ajog.2013.01.026","article-title":"Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers","volume":"208","author":"Singh","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clbc.2021.01.008_bib21","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1158\/1940-6207.CAPR-09-0130","article-title":"Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy","volume":"3","author":"Yi","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.clbc.2021.01.008_bib23","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/cncr.24199","article-title":"Perception of screening and risk-reduction surgeries in patients tested for a BRCA deleterious mutation","volume":"115","author":"Litton","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2021.01.008_bib24","first-page":"3748","article-title":"Predictors for contralateral prophylactic mastectomy in breast cancer patients","volume":"8","author":"Fu","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.clbc.2021.01.008_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10689-017-0001-2","article-title":"Heightened perception of breast cancer risk in young women at risk of familial breast cancer","volume":"17","author":"Glassey","year":"2018","journal-title":"Fam Cancer"},{"key":"10.1016\/j.clbc.2021.01.008_bib26","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1054\/bjoc.2000.1239","article-title":"Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer","volume":"83","author":"Verhoog","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2021.01.008_bib27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3390\/cancers12010140","article-title":"Contralateral prophylactic mastectomy in women with unilateral breast cancer who are genetic carriers, have a strong family history or are just young at presentation","volume":"12","author":"Teoh","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clbc.2021.01.008_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10549-018-5057-7","article-title":"Trends in use of bilateral prophylactic mastectomy vs high-risk surveillance in unaffected carriers of inherited breast cancer syndromes in the Inherited Cancer Registry (ICARE)","volume":"174","author":"Henry","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.01.008_bib29","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/jnci\/94.20.1564","article-title":"Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy","volume":"94","author":"Metcalfe","year":"2002","journal-title":"J\u00a0Natl Cancer Inst"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820921000203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820921000203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:21:14Z","timestamp":1761513674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820921000203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1526820921000203"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2021.01.008","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influential Factors on Risk-reduction Mastectomy in a High-risk Breast Cancer Population With Genetic Predispositions","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2021.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}